Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Role of CCK in anti-exploratory action of paroxetine, 5-HT reuptake inhibitor

Kõks, S., Bourin, M., Võikar, V., Soosaar, A. and Vasar, E. (1999) Role of CCK in anti-exploratory action of paroxetine, 5-HT reuptake inhibitor. The International Journal of Neuropsychopharmacology, 2 (1). pp. 9-16.

PDF - Published Version
Download (403kB) | Preview
Free to read:
*No subscription required


The administration of paroxetine (0.5–8 mg/kg), a selective 5-HT reuptake inhibitor, induced a dose-dependent reduction of exploratory activity of rats in the motility test. In the elevated plus-maze paroxetine was less effective, only 8 mg/kg of paroxetine decreased the exploratory behaviour of rats. The doses of paroxetine (2–8 mg/kg) reducing the exploratory activity in the motility test increased the density of CCK receptors in the frontal cortex, but not in the hippocampus. The treatment of rats with the CCKB receptor antagonist LY288,513 (0.01–1 mg/kg) did not change the exploratory activity. However, the reduction of exploratory activity induced by the low dose of paroxetine (2 mg/kg), but not by the higher dose (8 mg/kg), was dose-dependently reversed by the administration of LY288,513. Moreover, LY288,513 did not affect the anti-exploratory action of paroxetine (8 mg/kg) in the elevated plus-maze. Diazepam at doses (0.5–1.0 mg/kg) not suppressing the locomotor activity did not change the anti-exploratory action of paroxetine in the motility test. It is likely that the anti-exploratory action of a low dose of paroxetine (2 mg/kg) is not related to the increase in anxiety, but rather to the reduction of exploratory drive. Evidence exists that this effect of paroxetine is mediated via the activation of CCK-ergic transmission.

Item Type: Journal Article
Publisher: Collegium Internationale Neuropsychopharmacologicum
Copyright: © 1999 Collegium Internationale Neuro-Psychopharmacologicum
Item Control Page Item Control Page


Downloads per month over past year